OPTN (Option Therapeutics) Other Stockholders Equity: $1.20 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Option Therapeutics Other Stockholders Equity?

Option Therapeutics OPTN Other Stockholders Equity is $1.20 Mil as of Dec. 2025.

Option Therapeutics's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $1.20 Mil.

Option Therapeutics's quarterly Other Stockholders Equity increased from Jun. 2025 ($0.89 Mil) to Sep. 2025 ($1.09 Mil) and increased from Sep. 2025 ($1.09 Mil) to Dec. 2025 ($1.20 Mil).

Option Therapeutics's annual Other Stockholders Equity increased from . 20 ($0.00 Mil) to Jun. 2024 ($0.80 Mil) and increased from Jun. 2024 ($0.80 Mil) to Jun. 2025 ($0.89 Mil).

Option Therapeutics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Option Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Option Therapeutics Other Stockholders Equity Chart

Option Therapeutics Annual Data
Trend Jun24 Jun25
Other Stockholders Equity
0.80 0.89

Option Therapeutics Quarterly Data
Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial 0.00 0.00 0.89 1.09 1.20

Option Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $1.20 Mil mean?
Option Therapeutics (OPTN) has a Other Stockholders Equity of $1.20 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Option Therapeutics and its competitors.
Is Option Therapeutics' Other Stockholders Equity too high?
Option Therapeutics' current Other Stockholders Equity is $1.20 Mil.
How does Option Therapeutics' Other Stockholders Equity compare to ?
Option Therapeutics' Other Stockholders Equity of $1.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Option Therapeutics and its competitors. Option Therapeutics's current Other Stockholders Equity is $1.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Therapeutics stock overvalued right now?
Option Therapeutics (OPTN) has a current Other Stockholders Equity of $1.20 Mil. The current Other Stockholders Equity is $1.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Option Therapeutics (OPTN), the current Other Stockholders Equity is $1.20 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Option Therapeutics Business Description

Comparable Companies
Address 680 West Nye Lane, Suite 201, Carson, NV, USA, 89703
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.